Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Authors: Linda-Gail Bekker, Moupali Das, Quarraisha Abdool Karim, Khatija Ahmed, Joanne Batting, William Brumskine, Katherine Gill, Ishana Harkoo, Manjeetha Jaggernath, Godfrey Kigozi, Noah Kiwanuka, Philip Kotze, Limakatso Lebina, Cheryl E. Louw, Moelo Malahleha, Mmatsie Manentsa, Leila E. Mansoor, Dhayendre Moodley, Vimla Naicker, Logashvari Naidoo, Megeshinee Naidoo, Gonasagrie Nair, Nkosiphile Ndlovu, Thesla Palanee-Phillips, Ravindre Panchia, Saresha Pillay, Disebo Potloane, Pearl Selepe, Nishanta Singh, Yashna Singh, Elizabeth Spooner, Amy M. Ward, Zwelethu Zwane, Ramin Ebrahimi, Yang Zhao, Alexander Kintu, Chris Deaton, Christoph C. Carter, Jared M. Baeten, Flavia Matovu Kiweewa

Published: 2024-07-24

DOI: 10.1056/nejmoa2407001

Source: Full article


Abstract

No abstract found.